BIO Letter to Secretary Mayorkas on International Entrepreneur Rule
February 5, 2021
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time. The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch high-growth companies in the United States by utilizing the parole authority of the Department of Homeland Security (DHS). Unfortunately, the Trump Administration repeatedly sought to remove IER and block implementation before the program launched, thereby costing the United States jobs and innovation that are needed for our country to recover from the effects of the COVID-19 pandemic.
Download Full Comments Below
BIO Letter to Secretary Mayorkas on International Entrepreneur Rule
The Biotechnology Innovation Organization appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ Information Collection Request on the Part C and Part D Medicare Prescription Payment Plan Model Documents.
In response to their advance notice of proposed rulemaking (ANPRM), BIO submitted comments to the DOJ's National Security Division on implementing the White House Executive Order of February 28, 2024, “Preventing Access to Americans’ Bulk Sensitive…
We, the undersigned, are writing to express our strong concern with a proposed update to the Medicaid Drug Rebate Program. If finalized in its current form, the proposed rule (CMS-2434-P) would impose significant costs to the government and industry…
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time. The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch high-growth companies in the United States by utilizing the parole authority of the Department of Homeland Security (DHS). Unfortunately, the Trump Administration repeatedly sought to remove IER and block implementation before the program launched, thereby costing the United States jobs and innovation that are needed for our country to recover from the effects of the COVID-19 pandemic.